MedPageToday -- The experimental ion channel-regulating drug denufosol improves children’s lung function early in the course of cystic fibrosis, according to results of the first large phase III trial of the agent.
MedPageToday -- The experimental ion channel-regulating drug denufosol improves children’s lung function early in the course of cystic fibrosis, according to results of the first large phase III trial of the agent.
